Elevai Biosciences Highlights Preclinical Data Showing Potential of In-Licensed Asset “EL-22” for The Treatment of Obesity
May 02, 2024 08:30 ET
|
Elevai Labs Inc.
Elevai Biosciences Highlights Preclinical Data Showing Potential of In-Licensed Asset “EL-22” for The Treatment of Obesity
Elevai Labs Acquires Exclusive License to Two Myostatin Muscle Loss Prevention Assets with Plan to Develop in Combination with GLP-1 Obesity Treatments
May 01, 2024 09:00 ET
|
Elevai Labs Inc.
Elevai Labs Acquires Exclusive License to Two Myostatin Muscle Loss Prevention Assets with Plan to Develop in Combination with GLP-1 Obesity Treatments
UMeWorld Limited Updates Investors on Acquisition, Uplist and Relocation
April 30, 2024 08:00 ET
|
UMeWorld Limited
MIAMI, April 30, 2024 (GLOBE NEWSWIRE) -- UMeWorld Limited (OTC: UMEWF) is thankful to have the opportunity to update existing and future shareholders of the company operations and 2024 strategy...
Weight Loss Drugs Market Trends Analysis 2018-2023 and Opportunities Forecast 2024-2033 Featuring Pfizer, Roche, Merck & Co, AbbVie, and Novartis
April 24, 2024 04:12 ET
|
Research and Markets
Dublin, April 24, 2024 (GLOBE NEWSWIRE) -- The "Weight Loss Drugs Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The weight loss drugs market size has...
Enhanced Inventory Management Solutions to Meet Rising E-Commerce Demand
April 23, 2024 08:05 ET
|
LadyBug Resource Group, Inc.
Enhanced Inventory Management Solutions to Meet Rising E-Commerce Demand
Global Weight Loss Drugs Industry Research 2024: Market to Grow at a CAGR of 49.85% to 2029, Driven by Semaglutide (Ozempic and Wegovy), Liraglutide, and Tirzepatide (Marketed as Mounjaroy)
April 23, 2024 05:18 ET
|
Research and Markets
Dublin, April 23, 2024 (GLOBE NEWSWIRE) -- The "Global Weight Loss Drugs Market: Analysis By Product Type, By Drug Type, By Distribution Channel, By End User, By Region, Size and Trends with Impact...
United States Telehealth Weight Loss Market Report 2024: Surge in Telehealth Weight Loss Programs Amidst GLP-1 Medications Boom - Analysis, Forecasts, and Consolidation Insights for 2025
April 17, 2024 03:13 ET
|
Research and Markets
Dublin, April 17, 2024 (GLOBE NEWSWIRE) -- The "The U.S. Telehealth Weight Loss Market" report from Marketdata LLC has been added to ResearchAndMarkets.com's offering The report includes in-depth...
More Acquisitions on Horizon for Ladybug’s Growing E-Commerce Revenue Model
April 16, 2024 08:05 ET
|
LadyBug Resource Group, Inc.
MORE ACQUISITIONS ON HORIZON FOR LADYBUG’S GROWING E-COMMERCE REVENUE MODEL
New Nextech Med Spa for Wellness and Weight Loss Software Increases Average Patient Encounter Revenue by 70%
April 10, 2024 13:00 ET
|
Nextech Systems, Inc.
The new Nextech Med Spa for Wellness and Weight Loss empowers businesses with features like eRx and labs to easily expand their services and drive revenue.
Ladybug Resource Group Reports Revenue Spike Ending Q1-2024
April 09, 2024 08:05 ET
|
LadyBug Resource Group, Inc.
LADYBUG RESOURCE GROUP REPORTS REVENUE SPIKE ENDING Q1-2024